1. Novartis CEO Narasimhan touts blockbuster pipeline — Eli Lilly’s generic insulin to be half the price of branded counterpart — JNJ’s Invokana closes in on diabetic kidney disease approval -- See more on our front page news

    Got questions about whistleblowing?: Ask a Whistleblower Attorney
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Pharma/Biotech Companies - In the News

For the discussion of current news articles in the pharma/biotech space. Please provide a link to the article, and do not cut and paste whole articles due to copyright restrictions.

Sort By:
Title
Replies Views
Last Message ↓
  1. cafead
    Replies:
    0
    Views:
    39
  2. cafead
    Replies:
    0
    Views:
    25
  3. cafead
    Replies:
    0
    Views:
    32
  4. cafead
    Replies:
    0
    Views:
    43
  5. cafead
    Replies:
    0
    Views:
    27
  6. cafead
    Replies:
    0
    Views:
    38
  7. cafead
    Replies:
    0
    Views:
    52
  8. cafead
    Replies:
    0
    Views:
    24
  9. cafead
    Replies:
    0
    Views:
    24
  10. cafead
    Replies:
    0
    Views:
    20
  11. cafead
    Replies:
    0
    Views:
    21
  12. cafead
    Replies:
    0
    Views:
    29
  13. cafead
    Replies:
    0
    Views:
    30
  14. cafead
    Replies:
    0
    Views:
    23
  15. cafead
    Replies:
    0
    Views:
    36
  16. cafead
    Replies:
    0
    Views:
    26
  17. cafead
    Replies:
    0
    Views:
    41
  18. cafead
    Replies:
    0
    Views:
    34
  19. cafead
    Replies:
    0
    Views:
    43
  20. cafead
    Replies:
    0
    Views:
    25

Thread Display Options

Loading...